Clinical Trial Update: Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5) [Phase 3]

View source ↗

Summary

Phase 3 trial of Vicriviroc in treatment-experienced HIV patients has completed; the update does not detail results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Vicriviroc (MK-7690)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | Phase 3 | Status: COMPLETED